Softwr

Research · head to head

Greenphire vs NVivo

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
NVivo logo

NVivo

Research

Easy-to-use, collaborative qualitative analysis software

From
On request
Rated
-

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; NVivo base plan pricing not displayed on shop page; requires adding to cart or contacting sales
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and NVivo actually diverge.

Attributes where Greenphire and NVivo differ
AttributeGreenphireNVivo
PlatformsWeb, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in NVivo

Nothing recorded that Greenphire does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot NVivo
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot NVivo
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot NVivo
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot NVivo

NVivo

  • Qualitative data analysis for researchnot Greenphire
  • Document and interview coding and analysisnot Greenphire
  • Transcription and collaborative research projectsnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

NVivo

  • Base plan pricing not displayed on shop page; requires adding to cart or contacting sales
  • Volume licensing (10+ seats) requires sales contact only
  • No free version available, only trials without specified duration

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

NVivo

On request

No published plan breakdown. See the NVivo review.

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.

Choose NVivo if

Nothing in the data separates NVivo from Greenphire on the points above - pick on price and on how each one feels to use.

Questions people ask

Is Greenphire or NVivo better?
Neither clearly leads. Greenphire starts at On request and NVivo at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or NVivo?
Greenphire starts at On request and NVivo at On request.
Does Greenphire or NVivo run on more platforms?
Greenphire runs on Web, iOS, Android. NVivo runs on Web.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what NVivo is typically brought in for.
What can Greenphire do that NVivo cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

NVivo: How much does NVivo cost?

NVivo pricing is not displayed on the public website. Base plan pricing varies by subscription type and region. Individual/small teams can purchase directly through shop.lumivero.com, while organizations with 10+ licenses must contact sales for quotes.

Source
Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

NVivo: What are NVivo add-on costs?

NVivo AI Assistant costs $250 per year. Transcription costs $499 per year (50 hours annually) or $30 one-time (60 minutes). Collaboration Cloud for team sharing costs $99 per year.

Source
Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

NVivo: Does NVivo offer a free version?

No free version of NVivo is available. Free trials are available at the product website, though trial duration is not specified. Individual users can purchase licenses directly through lumivero.com.

Source
Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

NVivo: Is NVivo AI Assistant included in subscription?

No, NVivo AI Assistant is a paid add-on costing $250 per year. However, through August 18-September 15, 2026, AI Assistant is free with annual NVivo + AI subscriptions using code BTSAI100.

Source
Share

Related pages

Other head to heads